nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—CRABP2—forebrain—attention deficit hyperactivity disorder	0.0222	0.038	CbGeAlD
Tretinoin—RXRA—forebrain—attention deficit hyperactivity disorder	0.0221	0.0378	CbGeAlD
Tretinoin—ALDH1A2—cardiovascular system—attention deficit hyperactivity disorder	0.0215	0.0368	CbGeAlD
Tretinoin—ALDH1A1—forebrain—attention deficit hyperactivity disorder	0.0185	0.0316	CbGeAlD
Tretinoin—RXRG—cardiovascular system—attention deficit hyperactivity disorder	0.0164	0.0281	CbGeAlD
Tretinoin—CRABP1—midbrain—attention deficit hyperactivity disorder	0.0162	0.0277	CbGeAlD
Tretinoin—ALDH1A1—cardiovascular system—attention deficit hyperactivity disorder	0.0156	0.0268	CbGeAlD
Tretinoin—ALDH1A2—nervous system—attention deficit hyperactivity disorder	0.0138	0.0236	CbGeAlD
Tretinoin—RARRES1—brain—attention deficit hyperactivity disorder	0.0138	0.0235	CbGeAlD
Tretinoin—CRABP1—nervous system—attention deficit hyperactivity disorder	0.0133	0.0228	CbGeAlD
Tretinoin—ALDH1A2—central nervous system—attention deficit hyperactivity disorder	0.0133	0.0227	CbGeAlD
Tretinoin—ALDH1A2—cerebellum—attention deficit hyperactivity disorder	0.013	0.0222	CbGeAlD
Tretinoin—CRABP1—central nervous system—attention deficit hyperactivity disorder	0.0128	0.0219	CbGeAlD
Tretinoin—RXRG—midbrain—attention deficit hyperactivity disorder	0.0128	0.0219	CbGeAlD
Tretinoin—CRABP1—cerebellum—attention deficit hyperactivity disorder	0.0125	0.0214	CbGeAlD
Tretinoin—ALDH1A1—midbrain—attention deficit hyperactivity disorder	0.0122	0.0209	CbGeAlD
Tretinoin—CRABP2—nervous system—attention deficit hyperactivity disorder	0.012	0.0206	CbGeAlD
Tretinoin—RXRA—nervous system—attention deficit hyperactivity disorder	0.012	0.0205	CbGeAlD
Tretinoin—NR0B1—brain—attention deficit hyperactivity disorder	0.0118	0.0203	CbGeAlD
Tretinoin—CRABP2—central nervous system—attention deficit hyperactivity disorder	0.0116	0.0198	CbGeAlD
Tretinoin—RXRA—central nervous system—attention deficit hyperactivity disorder	0.0115	0.0198	CbGeAlD
Tretinoin—CRABP2—cerebellum—attention deficit hyperactivity disorder	0.0113	0.0194	CbGeAlD
Tretinoin—ALDH1A2—brain—attention deficit hyperactivity disorder	0.0106	0.0181	CbGeAlD
Tretinoin—RXRG—nervous system—attention deficit hyperactivity disorder	0.0105	0.018	CbGeAlD
Tretinoin—CRABP1—brain—attention deficit hyperactivity disorder	0.0102	0.0174	CbGeAlD
Tretinoin—RARB—cerebellum—attention deficit hyperactivity disorder	0.0101	0.0173	CbGeAlD
Tretinoin—RXRG—central nervous system—attention deficit hyperactivity disorder	0.0101	0.0173	CbGeAlD
Tretinoin—ALDH1A1—nervous system—attention deficit hyperactivity disorder	0.01	0.0172	CbGeAlD
Tretinoin—RXRB—nervous system—attention deficit hyperactivity disorder	0.0099	0.0169	CbGeAlD
Tretinoin—ALDH1A1—central nervous system—attention deficit hyperactivity disorder	0.00967	0.0165	CbGeAlD
Tretinoin—RXRB—central nervous system—attention deficit hyperactivity disorder	0.00953	0.0163	CbGeAlD
Tretinoin—ALDH1A1—cerebellum—attention deficit hyperactivity disorder	0.00945	0.0162	CbGeAlD
Tretinoin—RXRB—cerebellum—attention deficit hyperactivity disorder	0.00932	0.0159	CbGeAlD
Tretinoin—CRABP2—brain—attention deficit hyperactivity disorder	0.00921	0.0158	CbGeAlD
Tretinoin—RXRA—brain—attention deficit hyperactivity disorder	0.00917	0.0157	CbGeAlD
Tretinoin—RARG—nervous system—attention deficit hyperactivity disorder	0.00879	0.015	CbGeAlD
Tretinoin—RARG—central nervous system—attention deficit hyperactivity disorder	0.00846	0.0145	CbGeAlD
Tretinoin—RARG—cerebellum—attention deficit hyperactivity disorder	0.00827	0.0141	CbGeAlD
Tretinoin—RARA—nervous system—attention deficit hyperactivity disorder	0.00826	0.0141	CbGeAlD
Tretinoin—RARB—brain—attention deficit hyperactivity disorder	0.00824	0.0141	CbGeAlD
Tretinoin—RXRG—brain—attention deficit hyperactivity disorder	0.00805	0.0138	CbGeAlD
Tretinoin—RARA—central nervous system—attention deficit hyperactivity disorder	0.00796	0.0136	CbGeAlD
Tretinoin—RARA—cerebellum—attention deficit hyperactivity disorder	0.00778	0.0133	CbGeAlD
Tretinoin—ALDH1A1—brain—attention deficit hyperactivity disorder	0.00767	0.0131	CbGeAlD
Tretinoin—RXRB—brain—attention deficit hyperactivity disorder	0.00757	0.0129	CbGeAlD
Tretinoin—RARG—brain—attention deficit hyperactivity disorder	0.00672	0.0115	CbGeAlD
Tretinoin—RARA—brain—attention deficit hyperactivity disorder	0.00632	0.0108	CbGeAlD
Tretinoin—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.00549	0.00939	CbGeAlD
Tretinoin—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.00457	0.00783	CbGeAlD
Tretinoin—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00453	0.00775	CbGeAlD
Tretinoin—CYP2A6—brain—attention deficit hyperactivity disorder	0.00446	0.00763	CbGeAlD
Tretinoin—RXRG—Retinoic acid receptors-mediated signaling—EP300—attention deficit hyperactivity disorder	0.00362	0.00872	CbGpPWpGaD
Tretinoin—RARB—Retinoic acid receptors-mediated signaling—EP300—attention deficit hyperactivity disorder	0.00355	0.00856	CbGpPWpGaD
Tretinoin—RXRB—Retinoic acid receptors-mediated signaling—EP300—attention deficit hyperactivity disorder	0.00341	0.0082	CbGpPWpGaD
Tretinoin—RARA—Retinoic acid receptors-mediated signaling—EP300—attention deficit hyperactivity disorder	0.00341	0.0082	CbGpPWpGaD
Tretinoin—ALDH1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00338	0.00814	CbGpPWpGaD
Tretinoin—ALDH1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00336	0.00809	CbGpPWpGaD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00321	0.00773	CbGpPWpGaD
Tretinoin—NR0B1—Regulation of Androgen receptor activity—EP300—attention deficit hyperactivity disorder	0.00312	0.00751	CbGpPWpGaD
Tretinoin—CYP1A1—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00312	0.00751	CbGpPWpGaD
Tretinoin—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.00302	0.00517	CbGeAlD
Tretinoin—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.00294	0.00502	CbGeAlD
Tretinoin—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.00291	0.00498	CbGeAlD
Tretinoin—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.00283	0.00484	CbGeAlD
Tretinoin—NR0B1—Validated nuclear estrogen receptor alpha network—EP300—attention deficit hyperactivity disorder	0.00268	0.00645	CbGpPWpGaD
Tretinoin—CYP2C8—brain—attention deficit hyperactivity disorder	0.0025	0.00428	CbGeAlD
Tretinoin—CYP4A11—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00241	0.00581	CbGpPWpGaD
Tretinoin—CYP1A1—brain—attention deficit hyperactivity disorder	0.00231	0.00395	CbGeAlD
Tretinoin—RXRG—Regulation of Androgen receptor activity—EP300—attention deficit hyperactivity disorder	0.0023	0.00553	CbGpPWpGaD
Tretinoin—CYP2B6—brain—attention deficit hyperactivity disorder	0.00224	0.00384	CbGeAlD
Tretinoin—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00222	0.00379	CbGeAlD
Tretinoin—RXRB—Regulation of Androgen receptor activity—EP300—attention deficit hyperactivity disorder	0.00216	0.0052	CbGpPWpGaD
Tretinoin—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00214	0.00365	CbGeAlD
Tretinoin—RXRA—REV-ERBA represses gene expression—EP300—attention deficit hyperactivity disorder	0.00212	0.00511	CbGpPWpGaD
Tretinoin—CYP1A1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00211	0.00509	CbGpPWpGaD
Tretinoin—CYP2C18—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00211	0.00508	CbGpPWpGaD
Tretinoin—CYP1A1—Oxidative Stress—MAOA—attention deficit hyperactivity disorder	0.00206	0.00495	CbGpPWpGaD
Tretinoin—RXRA—RORA activates circadian gene expression—EP300—attention deficit hyperactivity disorder	0.00205	0.00495	CbGpPWpGaD
Tretinoin—CYP4A11—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00194	0.00468	CbGpPWpGaD
Tretinoin—RXRA—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00191	0.00461	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00181	0.00435	CbGpPWpGaD
Tretinoin—RXRA—Retinoic acid receptors-mediated signaling—EP300—attention deficit hyperactivity disorder	0.00178	0.00427	CbGpPWpGaD
Tretinoin—CYP4A11—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00173	0.00417	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00173	0.00417	CbGpPWpGaD
Tretinoin—RXRA—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00154	0.00371	CbGpPWpGaD
Tretinoin—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00153	0.00369	CbGpPWpGaD
Tretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—attention deficit hyperactivity disorder	0.0015	0.00361	CbGpPWpGaD
Tretinoin—CYP2C18—FOXA1 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00144	0.00347	CbGpPWpGaD
Tretinoin—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.0014	0.00338	CbGpPWpGaD
Tretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.0014	0.00337	CbGpPWpGaD
Tretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.0014	0.00337	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00138	0.00333	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00138	0.00333	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00138	0.00333	CbGpPWpGaD
Tretinoin—RXRA—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00137	0.00331	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.00132	0.00317	CbGpPWpGaD
Tretinoin—CYP4A11—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00129	0.00311	CbGpPWpGaD
Tretinoin—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00129	0.00309	CbGpPWpGaD
Tretinoin—CYP4A11—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00128	0.00309	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00126	0.00304	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00121	0.0029	CbGpPWpGaD
Tretinoin—CYP2C18—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00113	0.00272	CbGpPWpGaD
Tretinoin—RXRA—Regulation of Androgen receptor activity—EP300—attention deficit hyperactivity disorder	0.00113	0.00271	CbGpPWpGaD
Tretinoin—CYP2C18—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00112	0.0027	CbGpPWpGaD
Tretinoin—CYP2C18—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00111	0.00268	CbGpPWpGaD
Tretinoin—RXRA—Circadian Clock—EP300—attention deficit hyperactivity disorder	0.00109	0.00263	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.00106	0.00255	CbGpPWpGaD
Tretinoin—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00104	0.0025	CbGpPWpGaD
Tretinoin—CYP2A6—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00103	0.00249	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00103	0.00248	CbGpPWpGaD
Tretinoin—RXRA—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00102	0.00247	CbGpPWpGaD
Tretinoin—RXRA—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00102	0.00245	CbGpPWpGaD
Tretinoin—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00101	0.00244	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.00097	0.00233	CbGpPWpGaD
Tretinoin—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000958	0.00231	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000955	0.0023	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000955	0.0023	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000955	0.0023	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000955	0.0023	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000955	0.0023	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000955	0.0023	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000951	0.00229	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00094	0.00226	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00094	0.00226	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00094	0.00226	CbGpPWpGaD
Tretinoin—CYP2A6—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000922	0.00222	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000912	0.00219	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000912	0.00219	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000902	0.00217	CbGpPWpGaD
Tretinoin—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000878	0.00211	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000874	0.0021	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000874	0.0021	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000874	0.0021	CbGpPWpGaD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—EP300—attention deficit hyperactivity disorder	0.000836	0.00201	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000808	0.00195	CbGpPWpGaD
Tretinoin—CYP4A11—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000792	0.00191	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000775	0.00187	CbGpPWpGaD
Tretinoin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000775	0.00187	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000764	0.00184	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000764	0.00184	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000764	0.00184	CbGpPWpGaD
Tretinoin—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00075	0.00181	CbGpPWpGaD
Tretinoin—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000745	0.00179	CbGpPWpGaD
Tretinoin—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00074	0.00178	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000727	0.00175	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000727	0.00175	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000727	0.00175	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000727	0.00175	CbGpPWpGaD
Tretinoin—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000715	0.00172	CbGpPWpGaD
Tretinoin—CYP2A6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000688	0.00166	CbGpPWpGaD
Tretinoin—CYP2A6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000683	0.00164	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000665	0.0016	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000631	0.00152	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000631	0.00152	CbGpPWpGaD
Tretinoin—RXRA—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000628	0.00151	CbGpPWpGaD
Tretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000615	0.00148	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000579	0.00139	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000579	0.00139	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000579	0.00139	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000575	0.00138	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000575	0.00138	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000575	0.00138	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000557	0.00134	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000557	0.00134	CbGpPWpGaD
Tretinoin—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000555	0.00134	CbGpPWpGaD
Tretinoin—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000551	0.00133	CbGpPWpGaD
Tretinoin—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000547	0.00132	CbGpPWpGaD
Tretinoin—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000542	0.00131	CbGpPWpGaD
Tretinoin—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000539	0.0013	CbGpPWpGaD
Tretinoin—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000535	0.00129	CbGpPWpGaD
Tretinoin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000534	0.00129	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000528	0.00127	CbGpPWpGaD
Tretinoin—CYP1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000513	0.00123	CbGpPWpGaD
Tretinoin—CYP1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000509	0.00122	CbGpPWpGaD
Tretinoin—CYP1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000505	0.00122	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000475	0.00114	CbGpPWpGaD
Tretinoin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000471	0.00113	CbGpPWpGaD
Tretinoin—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00047	0.00113	CbGpPWpGaD
Tretinoin—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000467	0.00112	CbGpPWpGaD
Tretinoin—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000463	0.00112	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000462	0.00111	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00044	0.00106	CbGpPWpGaD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000424	0.00102	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000419	0.00101	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000404	0.000972	CbGpPWpGaD
Tretinoin—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000382	0.00092	CbGpPWpGaD
Tretinoin—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00038	0.000914	CbGpPWpGaD
Tretinoin—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000377	0.000908	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000365	0.000877	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000365	0.000877	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000359	0.000863	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000333	0.000802	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000319	0.000767	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000319	0.000767	CbGpPWpGaD
Tretinoin—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000314	0.000756	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000313	0.000755	CbGpPWpGaD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000308	0.00074	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000307	0.000739	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000291	0.000701	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000291	0.000701	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000289	0.000696	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000289	0.000696	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000284	0.000685	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000281	0.000677	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000277	0.000668	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000264	0.000636	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000255	0.000613	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000252	0.000607	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00025	0.000603	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000249	0.000599	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000248	0.000597	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000248	0.000597	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000248	0.000597	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000242	0.000584	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000231	0.000556	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000227	0.000546	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000222	0.000534	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—COMT—attention deficit hyperactivity disorder	0.000221	0.000532	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00022	0.00053	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000219	0.000528	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000213	0.000512	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000212	0.00051	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000212	0.00051	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000212	0.00051	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00021	0.000504	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000208	0.000502	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000194	0.000467	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000194	0.000467	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000194	0.000466	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—COMT—attention deficit hyperactivity disorder	0.000193	0.000465	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000192	0.000462	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000192	0.000461	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000191	0.00046	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000189	0.000455	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000178	0.000427	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—COMT—attention deficit hyperactivity disorder	0.000175	0.000422	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000174	0.000419	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000169	0.000408	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000169	0.000406	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000161	0.000388	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000157	0.000377	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000157	0.000377	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000156	0.000376	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000155	0.000374	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000154	0.000371	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000153	0.000369	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000153	0.000369	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000151	0.000363	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000148	0.000356	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000145	0.000348	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000145	0.000348	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000143	0.000345	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000142	0.000343	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00014	0.000337	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000133	0.000319	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000133	0.000319	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000132	0.000318	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00013	0.000314	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	0.000128	0.000309	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000127	0.000307	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000125	0.000301	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000122	0.000295	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000121	0.000292	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000119	0.000287	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000118	0.000283	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000117	0.000281	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000117	0.00028	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000116	0.000278	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00011	0.000265	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000108	0.00026	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000108	0.00026	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000106	0.000256	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000106	0.000255	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000103	0.000248	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000101	0.000243	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.87e-05	0.000238	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	9.49e-05	0.000228	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—EP300—attention deficit hyperactivity disorder	9.47e-05	0.000228	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	9.42e-05	0.000227	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	9.28e-05	0.000223	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	9.21e-05	0.000222	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	8.76e-05	0.000211	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.7e-05	0.000209	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.63e-05	0.000208	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.44e-05	0.000203	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—EP300—attention deficit hyperactivity disorder	8.28e-05	0.000199	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.21e-05	0.000198	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	8.04e-05	0.000193	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	7.98e-05	0.000192	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.74e-05	0.000186	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—EP300—attention deficit hyperactivity disorder	7.51e-05	0.000181	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	7.12e-05	0.000171	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.12e-05	0.000171	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	7e-05	0.000169	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	6.54e-05	0.000157	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.51e-05	0.000157	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	6.49e-05	0.000156	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.3e-05	0.000152	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.69e-05	0.000137	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	5.5e-05	0.000132	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.42e-05	0.00013	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	5.04e-05	0.000121	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	4.31e-05	0.000104	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	4.28e-05	0.000103	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	4.07e-05	9.8e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	3.98e-05	9.58e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	3.76e-05	9.05e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	3.45e-05	8.29e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	2.8e-05	6.75e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.85e-05	4.45e-05	CbGpPWpGaD
